Connection

LARRY LIPSHULTZ to Testosterone

This is a "connection" page, showing publications LARRY LIPSHULTZ has written about Testosterone.
Connection Strength

17.233
  1. Working Against the Clock: Depression and Hormonal Imbalance in Shift-Working Men. Urology. 2026 Feb; 208:194-198.
    View in: PubMed
    Score: 0.637
  2. Optimal restoration of spermatogenesis after testosterone therapy using human chorionic gonadotropin and follicle-stimulating hormone. Fertil Steril. 2025 Apr; 123(4):607-615.
    View in: PubMed
    Score: 0.591
  3. Occurrence of pulmonary oil microembolism (POME) with intramuscular testosterone undecanoate injection: literature review. Int J Impot Res. 2023 Aug; 35(5):439-446.
    View in: PubMed
    Score: 0.500
  4. Editorial Comment. J Urol. 2020 09; 204(3):562-563.
    View in: PubMed
    Score: 0.438
  5. Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members. Urology. 2020 05; 139:104-109.
    View in: PubMed
    Score: 0.427
  6. Testosterone therapy improves well being and psychological health. Curr Opin Urol. 2017 Nov; 27(6):519-524.
    View in: PubMed
    Score: 0.365
  7. Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers. J Sex Med. 2017 09; 14(9):1095-1103.
    View in: PubMed
    Score: 0.358
  8. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy. Fertil Steril. 2017 02; 107(2):351-357.e1.
    View in: PubMed
    Score: 0.341
  9. Testosterone Treatment in Older Men. N Engl J Med. 2016 07 07; 375(1):89.
    View in: PubMed
    Score: 0.333
  10. Basic concepts and recent advancements in the study of male fertility. Asian J Androl. 2016 May-Jun; 18(3):331.
    View in: PubMed
    Score: 0.329
  11. The importance of understanding baseline reproductive function prior to the administration of exogenous testosterone. Asian J Androl. 2016 May-Jun; 18(3):381.
    View in: PubMed
    Score: 0.329
  12. Testosterone and Male Infertility. Urol Clin North Am. 2016 May; 43(2):195-202.
    View in: PubMed
    Score: 0.326
  13. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis. Eur Urol. 2016 06; 69(6):1083-90.
    View in: PubMed
    Score: 0.324
  14. Dietary Adjuncts for Improving Testosterone Levels in Hypogonadal Males. Am J Mens Health. 2016 11; 10(6):NP109-NP117.
    View in: PubMed
    Score: 0.313
  15. Association Between Testosterone Supplementation Therapy and Thrombotic Events in Elderly Men. Urology. 2015 Aug; 86(2):283-5.
    View in: PubMed
    Score: 0.312
  16. Reply: To PMID 26299630. Urology. 2015 Aug; 86(2):285-6.
    View in: PubMed
    Score: 0.312
  17. Association of Free Testosterone With Hypogonadal Symptoms in Men With Near-normal Total Testosterone Levels. Urology. 2015 Aug; 86(2):287-90.
    View in: PubMed
    Score: 0.311
  18. Words of Wisdom. Re: incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries. Eur Urol. 2015 Jun; 67(6):1186-7.
    View in: PubMed
    Score: 0.308
  19. The Use of HCG-Based Combination Therapy for Recovery of Spermatogenesis after Testosterone Use. J Sex Med. 2015 Jun; 12(6):1334-7.
    View in: PubMed
    Score: 0.306
  20. Hypogonadal symptoms in young men are associated with a serum total testosterone threshold of 400 ng/dL. BJU Int. 2015 Jul; 116(1):142-6.
    View in: PubMed
    Score: 0.303
  21. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015 Mar-Apr; 17(2):197-200.
    View in: PubMed
    Score: 0.303
  22. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis. J Urol. 2015 Jul; 194(1):160-5.
    View in: PubMed
    Score: 0.300
  23. Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med. 2014 Nov; 126(7):149-56.
    View in: PubMed
    Score: 0.296
  24. Testosterone therapy and cancer risk. BJU Int. 2015 Feb; 115(2):317-21.
    View in: PubMed
    Score: 0.296
  25. Vasectomy reversal outcomes in men previously on testosterone supplementation therapy. Urology. 2014 Dec; 84(6):1335-40.
    View in: PubMed
    Score: 0.295
  26. Reply: To PMID 25307733. Urology. 2014 Dec; 84(6):1341.
    View in: PubMed
    Score: 0.295
  27. Hypogonadal symptoms are associated with different serum testosterone thresholds in middle-aged and elderly men. Urology. 2014 Dec; 84(6):1378-82.
    View in: PubMed
    Score: 0.295
  28. Word of wisdom. Re: testosterone lab testing and initiation in the United kingdom and the United States, 2000 to 2011. Eur Urol. 2014 Oct; 66(4):786-7.
    View in: PubMed
    Score: 0.294
  29. Effect of testosterone supplementation on symptoms in men with hypogonadism. Eur Urol. 2015 Jan; 67(1):176-177.
    View in: PubMed
    Score: 0.293
  30. Testosterone therapy and mortality risk. Int J Impot Res. 2015 Mar-Apr; 27(2):46-8.
    View in: PubMed
    Score: 0.291
  31. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.291
  32. Re: Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. Eur Urol. 2014 Jul; 66(1):175-6.
    View in: PubMed
    Score: 0.289
  33. Relationship between testosterone and sexual function in infertile men. Fertil Steril. 2014 Jun; 101(6):1584.
    View in: PubMed
    Score: 0.285
  34. Words of wisdom. Re: Gonadal steroids and body composition, strength, and sexual function in men. Eur Urol. 2014 Apr; 65(4):843-4.
    View in: PubMed
    Score: 0.284
  35. Words of wisdom. Re: In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. Eur Urol. 2014 Apr; 65(4):844-5.
    View in: PubMed
    Score: 0.284
  36. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy. J Urol. 2014 Sep; 192(3):875-9.
    View in: PubMed
    Score: 0.284
  37. Elevated serum estradiol is associated with higher libido in men on testosterone supplementation therapy. Eur Urol. 2014 Jun; 65(6):1224-5.
    View in: PubMed
    Score: 0.281
  38. Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med. 2014 Feb; 11(2):553-62.
    View in: PubMed
    Score: 0.277
  39. Factors influencing patient decisions to initiate and discontinue subcutaneous testosterone pellets (Testopel) for treatment of hypogonadism. J Sex Med. 2013 Sep; 10(9):2326-33.
    View in: PubMed
    Score: 0.271
  40. Editorial comment. Urology. 2013 Jun; 81(6):1217-8.
    View in: PubMed
    Score: 0.265
  41. The evidence for seasonal variations of testosterone in men. Maturitas. 2013 Mar; 74(3):208-12.
    View in: PubMed
    Score: 0.261
  42. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013 Feb; 189(2):647-50.
    View in: PubMed
    Score: 0.260
  43. The significance of insulin-like factor 3 as a marker of intratesticular testosterone. Fertil Steril. 2013 Jan; 99(1):66-67.
    View in: PubMed
    Score: 0.258
  44. Seasonal fluctuations in testosterone-estrogen ratio in men from the Southwest United States. J Androl. 2012 Nov-Dec; 33(6):1298-304.
    View in: PubMed
    Score: 0.252
  45. The relationship between anogenital distance and reproductive hormone levels in adult men. J Urol. 2012 Feb; 187(2):594-8.
    View in: PubMed
    Score: 0.243
  46. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.199
  47. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy. Int J Impot Res. 2008 Nov-Dec; 20(6):561-5.
    View in: PubMed
    Score: 0.195
  48. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.182
  49. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Int J Impot Res. 2008 Mar-Apr; 20(2):213-7.
    View in: PubMed
    Score: 0.181
  50. Testosterone replacement therapy in men on active surveillance for prostate cancer. J Sex Med. 2025 04 08; 22(3):432-438.
    View in: PubMed
    Score: 0.153
  51. Creatinine and Cystatin C: A Measure of Renal Function in Men With Testosterone-Induced Muscle Hypertrophy. Am J Mens Health. 2024 Sep-Oct; 18(5):15579883241286654.
    View in: PubMed
    Score: 0.146
  52. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.112
  53. Shift Work Sleep Disorder and Night Shift Work Significantly Impair Erectile Function. J Sex Med. 2020 09; 17(9):1687-1693.
    View in: PubMed
    Score: 0.110
  54. Obstructive Sleep Apnea and Testosterone Therapy. Sex Med Rev. 2021 04; 9(2):296-303.
    View in: PubMed
    Score: 0.110
  55. Increased Risk of Hypogonadal Symptoms in Shift Workers With Shift Work Sleep Disorder. Urology. 2020 04; 138:52-59.
    View in: PubMed
    Score: 0.106
  56. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL. Int Braz J Urol. 2019 Sep-Oct; 45(5):1008-1012.
    View in: PubMed
    Score: 0.104
  57. Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements. J Sex Med. 2019 02; 16(2):203-212.
    View in: PubMed
    Score: 0.099
  58. Iron and a Man's Reproductive Health: the Good, the Bad, and the Ugly. Curr Urol Rep. 2018 Jun 01; 19(8):60.
    View in: PubMed
    Score: 0.095
  59. Men with a complete absence of normal sperm morphology exhibit high rates of success without assisted reproduction. Asian J Androl. 2017 Jan-Feb; 19(1):39-42.
    View in: PubMed
    Score: 0.086
  60. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert Opin Pharmacother. 2016 Aug; 17(11):1561-7.
    View in: PubMed
    Score: 0.083
  61. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.077
  62. Current state of practice regarding testosterone supplementation therapy in men with prostate cancer. Steroids. 2014 Nov; 89:27-32.
    View in: PubMed
    Score: 0.073
  63. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a?randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014 Sep; 102(3):720-7.
    View in: PubMed
    Score: 0.073
  64. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.066
  65. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9.
    View in: PubMed
    Score: 0.064
  66. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013 Jan; 25(1):24-8.
    View in: PubMed
    Score: 0.064
  67. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.062
  68. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.060
  69. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.057
  70. Estradiol exerts alterations in sexual function and fertility in human males. Asian J Androl. 2016 May-Jun; 18(3):441.
    View in: PubMed
    Score: 0.021
  71. The clinical characteristics of 82 patients with Sertoli cell-only testis histology. Fertil Steril. 1995 Dec; 64(6):1197-200.
    View in: PubMed
    Score: 0.020
  72. The reversibility of anabolic steroid-induced azoospermia. J Urol. 1995 May; 153(5):1628-30.
    View in: PubMed
    Score: 0.019
  73. Depression is correlated with the psychological and physical aspects of sexual dysfunction in men. Int J Impot Res. 2013 Sep; 25(5):194-9.
    View in: PubMed
    Score: 0.017
  74. Semen quality and endocrine parameters after acute testicular torsion. J Urol. 1992 Jun; 147(6):1545-50.
    View in: PubMed
    Score: 0.016
  75. IGF-1 levels are significantly correlated with patient-reported measures of sexual function. Int J Impot Res. 2011 Sep-Oct; 23(5):220-6.
    View in: PubMed
    Score: 0.015
  76. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 2010 Jan-Feb; 22(1):20-4.
    View in: PubMed
    Score: 0.013
  77. The effect of estrogen on Sertoli cell function. J Urol. 1982 Sep; 128(3):642-4.
    View in: PubMed
    Score: 0.008
  78. Testicular function among epichlorohydrin workers. Br J Ind Med. 1981 Nov; 38(4):372-7.
    View in: PubMed
    Score: 0.008
  79. Recovery from severe oligospermia after exposure to dibromochloropropane. Fertil Steril. 1981 Jan; 35(1):46-53.
    View in: PubMed
    Score: 0.007
  80. Dibromochloropropane and its effect on testicular function in man. J Urol. 1980 Oct; 124(4):464-8.
    View in: PubMed
    Score: 0.007
  81. Supranormal FSH response to gonadotrophin-releasing hormone in oligospermic men with a normal basal serum FSH concentration. Clin Endocrinol (Oxf). 1977 Aug; 7(2):103-9.
    View in: PubMed
    Score: 0.006
  82. Endocrinologic and radiographic evaluation of cryptorchid testes. Birth Defects Orig Artic Ser. 1977; 13(5):275-85.
    View in: PubMed
    Score: 0.005
  83. Testicular function after orchiopexy for unilaterally undescended testis. N Engl J Med. 1976 Jul 01; 295(1):15-8.
    View in: PubMed
    Score: 0.005
  84. Delta-9-tetrahydrocannabinol stimulates ABP secretion from rat Sertoli cells in vitro. J Steroid Biochem. 1986 Mar; 24(3):687-93.
    View in: PubMed
    Score: 0.003
  85. Structure and biochemistry of the Sertoli cell. Int Rev Cytol. 1985; 94:127-49.
    View in: PubMed
    Score: 0.002
  86. Effect of cannabinoids on human Sertoli cell function in vitro. Arch Androl. 1983 Dec; 11(3):245-51.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.